HK1205735A1 - Fluorinated 2-amino-4-(benzylamino)phenylcarbamate derivatives 2--4() - Google Patents
Fluorinated 2-amino-4-(benzylamino)phenylcarbamate derivatives 2--4()Info
- Publication number
- HK1205735A1 HK1205735A1 HK15106176.6A HK15106176A HK1205735A1 HK 1205735 A1 HK1205735 A1 HK 1205735A1 HK 15106176 A HK15106176 A HK 15106176A HK 1205735 A1 HK1205735 A1 HK 1205735A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- benzylamino
- fluorinated
- amino
- phenylcarbamate derivatives
- phenylcarbamate
- Prior art date
Links
- BCOXRRQTBPXQQS-UHFFFAOYSA-N C1=C(NC(O)=O)C(N)=CC(NCC=2C=CC=CC=2)=C1 Chemical class C1=C(NC(O)=O)C(N)=CC(NCC=2C=CC=CC=2)=C1 BCOXRRQTBPXQQS-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
- A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/001—Acyclic or carbocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/006—Palladium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Addiction (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261640157P | 2012-04-30 | 2012-04-30 | |
US201261697690P | 2012-09-06 | 2012-09-06 | |
PCT/US2013/030984 WO2013165575A1 (en) | 2012-04-30 | 2013-03-13 | Fluorinated 2-amino-4-(benzylamino)phenylcarbamate derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1205735A1 true HK1205735A1 (en) | 2015-12-24 |
Family
ID=49477476
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15106176.6A HK1205735A1 (en) | 2012-04-30 | 2015-06-29 | Fluorinated 2-amino-4-(benzylamino)phenylcarbamate derivatives 2--4() |
Country Status (11)
Country | Link |
---|---|
US (3) | US8916133B2 (fi) |
EP (1) | EP2844639A4 (fi) |
JP (1) | JP6195906B2 (fi) |
KR (1) | KR20150053257A (fi) |
CN (1) | CN104470893A (fi) |
AU (2) | AU2013257209B2 (fi) |
CA (1) | CA2870095A1 (fi) |
HK (1) | HK1205735A1 (fi) |
IL (1) | IL235012A (fi) |
MX (1) | MX2014013166A (fi) |
WO (1) | WO2013165575A1 (fi) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2013257209B2 (en) * | 2012-04-30 | 2016-05-19 | Scifluor Life Sciences, Inc | Fluorinated 2-amino-4-(benzylamino)phenylcarbamate derivatives |
JP2015178576A (ja) * | 2014-03-19 | 2015-10-08 | 富士フイルム株式会社 | 化合物、着色組成物、インクジェット記録用インク、インクジェット記録方法、インクジェットプリンタカートリッジ、及びインクジェット記録物 |
WO2016077724A1 (en) * | 2014-11-13 | 2016-05-19 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | (2-amino-4(arylamino)phenyl) carbamates |
RU2018147263A (ru) | 2016-06-10 | 2020-07-10 | Сайфлуор Лайф Сайенсиз, Инк | Фторированные 2-амино-4-(замещенные амино)фенилкарбаматные производные |
WO2018048882A1 (en) | 2016-09-06 | 2018-03-15 | The Research Foundation For The State University Of New York | Positron imaging tomography imaging agent composition and method for bacterial infection |
CN107935858B (zh) * | 2016-10-12 | 2020-09-08 | 利尔化学股份有限公司 | 5-氟-2-硝基苯酚的制备方法 |
US11197709B2 (en) | 2017-03-13 | 2021-12-14 | Medtronic Advanced Energy Llc | Electrosurgical system |
JP2021506810A (ja) * | 2017-12-13 | 2021-02-22 | サイフルーア ライフ サイエンシズ インコーポレイテッド | フッ素化4−(置換アミノ)フェニルカルバメート誘導体 |
US11358930B2 (en) | 2018-04-20 | 2022-06-14 | University of Pittsburgh—of the Commonwealth System of Higher Education | Selective potassium channel agonists |
DE102018212006B3 (de) * | 2018-07-18 | 2019-10-31 | Universität Greifswald | Thioether als Modulatoren von Kv7.2/Kv7.3-Kanälen |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4200259A1 (de) * | 1992-01-08 | 1993-07-15 | Asta Medica Ag | Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung |
GB9915414D0 (en) * | 1999-07-01 | 1999-09-01 | Glaxo Group Ltd | Medical use |
TWI287984B (en) * | 2000-10-17 | 2007-10-11 | Wyeth Corp | Pharmaceutical composition for modulating bladder function |
US6589986B2 (en) * | 2000-12-20 | 2003-07-08 | Wyeth | Methods of treating anxiety disorders |
AU2002338333A1 (en) * | 2001-04-04 | 2002-10-21 | Wyeth | Methods for treating hyperactive gastric motility |
US8722929B2 (en) * | 2006-10-10 | 2014-05-13 | Valeant Pharmaceuticals International | N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators |
AU2009271302A1 (en) * | 2008-06-24 | 2010-01-21 | Valeant Pharmaceuticals International | Benzyloxy anilide derivatives useful as potassium channel modulators |
AU2013257209B2 (en) * | 2012-04-30 | 2016-05-19 | Scifluor Life Sciences, Inc | Fluorinated 2-amino-4-(benzylamino)phenylcarbamate derivatives |
-
2013
- 2013-03-13 AU AU2013257209A patent/AU2013257209B2/en not_active Ceased
- 2013-03-13 CA CA2870095A patent/CA2870095A1/en not_active Abandoned
- 2013-03-13 WO PCT/US2013/030984 patent/WO2013165575A1/en active Application Filing
- 2013-03-13 CN CN201380034998.0A patent/CN104470893A/zh active Pending
- 2013-03-13 MX MX2014013166A patent/MX2014013166A/es unknown
- 2013-03-13 JP JP2015510264A patent/JP6195906B2/ja not_active Expired - Fee Related
- 2013-03-13 US US13/801,634 patent/US8916133B2/en not_active Expired - Fee Related
- 2013-03-13 EP EP13784431.2A patent/EP2844639A4/en not_active Withdrawn
- 2013-03-13 KR KR1020147030410A patent/KR20150053257A/ko not_active Application Discontinuation
-
2014
- 2014-10-06 IL IL235012A patent/IL235012A/en active IP Right Grant
- 2014-12-10 US US14/566,167 patent/US9556114B2/en not_active Expired - Fee Related
-
2015
- 2015-06-29 HK HK15106176.6A patent/HK1205735A1/xx unknown
-
2016
- 2016-07-19 AU AU2016206246A patent/AU2016206246B2/en not_active Ceased
- 2016-12-15 US US15/380,216 patent/US20170096390A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US9556114B2 (en) | 2017-01-31 |
IL235012A (en) | 2017-09-28 |
US20170096390A1 (en) | 2017-04-06 |
US8916133B2 (en) | 2014-12-23 |
EP2844639A1 (en) | 2015-03-11 |
KR20150053257A (ko) | 2015-05-15 |
AU2016206246A1 (en) | 2016-08-04 |
JP2015516988A (ja) | 2015-06-18 |
US20150098902A1 (en) | 2015-04-09 |
MX2014013166A (es) | 2015-05-11 |
CA2870095A1 (en) | 2013-11-07 |
JP6195906B2 (ja) | 2017-09-13 |
WO2013165575A1 (en) | 2013-11-07 |
US20130287686A1 (en) | 2013-10-31 |
AU2013257209B2 (en) | 2016-05-19 |
CN104470893A (zh) | 2015-03-25 |
AU2016206246B2 (en) | 2017-06-15 |
EP2844639A4 (en) | 2015-12-23 |
AU2013257209A1 (en) | 2014-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1205735A1 (en) | Fluorinated 2-amino-4-(benzylamino)phenylcarbamate derivatives 2--4() | |
ZA201702364B (en) | Glucagon analogues | |
HK1221632A1 (zh) | 緶織支撐架 | |
HK1206757A1 (en) | Glucagon analogues | |
EP2912644A4 (en) | PORTABLE OBJECT RETRIEVING SOMATIC SENSOR INFORMATION | |
EP2837171A4 (en) | CAMERA | |
SG11201404663RA (en) | Electroformed sheath | |
EP2828745A4 (en) | UPDATING SOFTWARE COMPONENTS | |
GB2500671B (en) | Camera assembly | |
IL236982A (en) | Carbmats | |
GB2544031B (en) | Flexible computing fabric | |
PL2822903T3 (pl) | Przegubowe podparcie do gięcia | |
EP2931693A4 (en) | PARTIALLY FLUORINATED COMPOUNDS | |
EP2908167A4 (en) | PORTABLE BINOCULAR | |
EP2958568A4 (en) | PHOSPHAPLATINES AS NEUROPROTECTIVE AGENTS | |
GB201311581D0 (en) | Biomedical scaffold | |
GB201316050D0 (en) | Deuterated compounds | |
GB201315602D0 (en) | Bend stiffener | |
GB2499115B (en) | Camera | |
HK1207634A1 (en) | Substituted phenylcarbamate compounds | |
HK1206745A1 (en) | Schweinfurthin analogues schweinfurthin | |
GB2506656B (en) | Masonry support attachment | |
EP2894366A4 (en) | SHOCK ABSORBING LINK | |
GB201218541D0 (en) | Fixing template | |
GB201207350D0 (en) | Fluorinated alicyclic compounds |